Nectar Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Cash & Equivalents	-	192.22	198.06	175.8	178.08	255.39	Upgrade
Short-Term Investments	-	-	-	-	-	4.57	Upgrade
Trading Asset Securities	-	5.3	4.95	3.14	4.6	-	Upgrade
Cash & Short-Term Investments	197.51	197.52	203.01	178.94	182.68	259.96	Upgrade
Cash Growth	-2.71%	-2.70%	13.45%	-2.05%	-29.73%	21.14%	Upgrade
Accounts Receivable	-	3,455	3,792	2,796	4,470	3,748	Upgrade
Other Receivables	-	459.73	423.11	637.78	670.53	463.64	Upgrade
Receivables	-	3,923	4,224	3,438	5,144	4,216	Upgrade
Inventory	-	7,423	7,765	7,315	7,213	6,553	Upgrade
Other Current Assets	-	832.25	645.76	1,380	1,009	1,359	Upgrade
Total Current Assets	-	12,376	12,838	12,312	13,548	12,388	Upgrade
Property, Plant & Equipment	-	6,333	6,561	6,904	7,652	8,322	Upgrade
Long-Term Investments	-	2.35	2.35	2.35	2.35	2.35	Upgrade
Other Intangible Assets	-	565.04	523.93	493.29	430.21	383.64	Upgrade
Long-Term Accounts Receivable	-	84.87	81.54	73.46	78.28	102.89	Upgrade
Long-Term Deferred Tax Assets	-	550.41	74.78	205.69	28	122.79	Upgrade
Other Long-Term Assets	-	560.38	1,829	1,901	2,169	2,560	Upgrade
Total Assets	-	20,472	21,911	21,892	23,908	23,881	Upgrade
Accounts Payable	-	4,381	4,197	3,188	3,767	3,422	Upgrade
Accrued Expenses	-	151.35	153.5	104.43	510.46	144.13	Upgrade
Short-Term Debt	-	4,402	4,122	4,589	5,028	7,120	Upgrade
Current Portion of Long-Term Debt	-	816.8	830.09	684.45	660.81	631.67	Upgrade
Other Current Liabilities	-	463.95	425.78	343.74	72.85	556.55	Upgrade
Total Current Liabilities	-	10,215	9,728	8,909	10,038	11,874	Upgrade
Long-Term Debt	-	601.27	1,403	2,265	2,911	1,282	Upgrade
Long-Term Unearned Revenue	-	7.21	7.46	7.71	7.96	8.21	Upgrade
Other Long-Term Liabilities	-	0.01	-0.01	0.01	8.3	18.95	Upgrade
Total Liabilities	-	10,911	11,218	11,246	13,029	13,261	Upgrade
Common Stock	-	224.26	224.26	224.26	224.26	224.26	Upgrade
Additional Paid-In Capital	-	3,288	3,288	3,288	3,288	3,288	Upgrade
Retained Earnings	-	6,049	7,180	7,134	7,367	7,108	Upgrade
Shareholders' Equity	9,561	9,561	10,692	10,646	10,879	10,620	Upgrade
Total Liabilities & Equity	-	20,472	21,911	21,892	23,908	23,881	Upgrade
Total Debt	5,820	5,820	6,355	7,538	8,599	9,034	Upgrade
Net Cash (Debt)	-5,623	-5,623	-6,152	-7,359	-8,417	-8,774	Upgrade
Net Cash Per Share	-25.19	-25.07	-27.43	-32.82	-37.53	-39.12	Upgrade
Filing Date Shares Outstanding	224.22	224.26	224.26	224.26	224.26	224.26	Upgrade
Total Common Shares Outstanding	224.22	224.26	224.26	224.26	224.26	224.26	Upgrade
Working Capital	-	2,160	3,110	3,403	3,510	514.36	Upgrade
Book Value Per Share	42.63	42.63	47.68	47.47	48.51	47.36	Upgrade
Tangible Book Value	8,996	8,996	10,169	10,153	10,449	10,237	Upgrade
Tangible Book Value Per Share	40.11	40.11	45.34	45.27	46.59	45.65	Upgrade
Land	-	192.35	192.35	192.35	516.05	806.42	Upgrade
Buildings	-	1,818	1,803	1,760	1,773	1,750	Upgrade
Machinery	-	10,451	10,186	10,011	9,936	9,753	Upgrade
Construction In Progress	-	567.28	657.5	777.83	850.98	986.29	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.